Oct 312017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Xenetic Biosciences, Inc. (NASDAQ: XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics, announced today that it has appointed Jeffrey F.=> Read more

Xenetic Biosciences appoints COO Jeff Eisenberg as new CEO

From:: Xenetic Biosciences appoints COO Jeff Eisenberg as new CEO

Sorry, the comment form is closed at this time.

%d bloggers like this: